| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000033789 |
| Receipt No. | R000038535 |
| Scientific Title | The effects of dietary novel chocolate on postprandial blood glucose level in healthy adult men |
| Date of disclosure of the study information | 2019/03/01 |
| Last modified on | 2019/08/14 (Ver. 3) |
| Basic information | ||
| Public title | The effects of dietary novel chocolate on postprandial blood glucose level in healthy adult men | |
| Acronym | The effects of dietary novel chocolate on postprandial blood glucose | |
| Scientific Title | The effects of dietary novel chocolate on postprandial blood glucose level in healthy adult men | |
| Scientific Title:Acronym | The effects of dietary novel chocolate on postprandial blood glucose | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult males | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We randomly allocated twelve subjects to administer either the novel chocolate or the control chocolate to investigate the postprandial blood glucose level, followed by a washout period. These subjects were then crossed over and received the alternative chocolate. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Blood glucose level, the blood glucose areas under the curve (AUC), the maximum (Cmax) blood glucose level |
| Key secondary outcomes | Blood insulin level, the blood insulin areas under the curve (AUC), the maximum (Cmax) blood insulin level |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Single dose administration of 65 g of the novel chocolate in intervention period | |
| Interventions/Control_2 | Single dose administration of 65 g of the control chocolate in control period | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male | |||
| Key inclusion criteria | 1) All subjects voluntarily signed the informed consent after detailed description and understanding of this study
2) Those who belong to a particular company. 3) Subjects with fasting blood glucose level within normal range between 70 mg/dL and 110 mg/dL using the first blood test. |
|||
| Key exclusion criteria | 1) Those who administer 'Food for Specified Health Use','Foods with Function Clai s' or medicine to have effects on blood glucose metabolism.
2) Patients with diseases undergoing treatments or with medical history of severe diseases that required medication therapy. 3) Those who may suffer from allergy by administering cacao, milk or soybean. 4) Those who were included other clinical trials within one month before giving written informed consent, or during this study. 5) Any other medical and/or health reasons unfavorable to participation in this study, as judged by the principal investigator. |
|||
| Target sample size | 12 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kurihara Clinic, Nihonbashi, Tokyo | ||||||
| Division name | Kurihara Clinic, Nihonbashi, Tokyo | ||||||
| Zip code | |||||||
| Address | 3-2-6 Nihonbashi, Chuoku, Tokyo 103-0027 | ||||||
| TEL | 03-3516-2200 | ||||||
| kurihara@k-sarasara.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Meiji Co., Ltd. | ||||||
| Division name | Clinical Study Group | ||||||
| Zip code | |||||||
| Address | 1-29-1 Nanakuni, Hachiouji, Tokyo 192-0919 | ||||||
| TEL | 042-632-5807 | ||||||
| Homepage URL | |||||||
| takaya.kitamura@meiji.com | |||||||
| Sponsor | |
| Institute | Meiji Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Meiji Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 栗原クリニック 東京・日本橋(東京都) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |||||||
| URL related to results and publications | |||||||
| Number of participants that the trial has enrolled | 10 | ||||||
| Results | 1) Blood glucose at 30 minutes after ingestion of the test diet was significantly lower than after ingestion of the control diet. 2) Plasma insulin levels at 30 and 60 minutes after ingestion of the test diet were also significantly lower than after ingestion of the control diet. 3) The change in area under the curve(delta AUC)of plasma insulin levels following ingestion of the test diet was significantly lower than that following ingestion of the control diet. |
||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results |
|
||||||
| Baseline Characteristics | |||||||
| Participant flow | |||||||
| Adverse events | None |
||||||
| Outcome measures | |||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038535 |